TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors

Clinical trial NCT07713732 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07713732
Sponsor: Treeline Biosciences, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer ( SCLC )Neuroendocrine Cancer Malignant Pleural Mesotheliomas (Mpm)Synovial Sarcomas

Start date: 2026-07-25
Primary completion: 2030-08-29
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.